Skip to main content
Daniel Hayes, MD, Oncology, Ann Arbor, MI

DanielFHayesMD

Oncology Ann Arbor, MI

Professor of Medicine, University Mich Medical School

Dr. Hayes is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hayes' full profile

Already have an account?

  • Office

    1500 E Medical Center Dr
    Ann Arbor, MI 48109
    Phone+1 734-936-4000

Summary

  • Medical Oncologist with focus on Breast Cancer at University of Michigan Rogel Cancer Center

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1982 - 1984
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterInternship, Internal Medicine, 1979 - 1980
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1979

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1982 - 2023
  • MI State Medical License
    MI State Medical License 2001 - 2023
  • DC State Medical License
    DC State Medical License 1996 - 2002
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • An International Multicenter Study to Evaluate Reproducibility of Automated Scoring for Assessment of Ki67 in Breast Cancer  
    Richard Levenson, David L Rimm, Daniel F Hayes, Chad Galderisi, Liron Pantanowitz, Nature
  • Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer  
    Matthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine

Other

Press Mentions

  • Invasive DFS Improvements Maintained in Final KATHERINE Data
    Invasive DFS Improvements Maintained in Final KATHERINE DataJanuary 15th, 2025
  • David Smith Retires with a Legacy of Compassionate Patient Care
    David Smith Retires with a Legacy of Compassionate Patient CareOctober 16th, 2024
  • CTC-Guided Therapy Beats Physician Choice in Metastatic Breast Cancer
    CTC-Guided Therapy Beats Physician Choice in Metastatic Breast CancerDecember 15th, 2022
  • Join now to see all

Grant Support

  • Effects Of Exemestane Or Letrozole On Surrogate Markers Of ResponseNational Center For Research Resources2007
  • Pilot Trial Correlating Metabolic Profile Of Tamoxifen With HOT FlashesNational Center For Research Resources2004–2007
  • A Multi-Center Randomized Clinical Trial Correlating The Effects Of 24 Months OfNational Center For Research Resources2006
  • Correlative Studies Of Erbb-2/Her2 And P53 In Calgb PRO.National Cancer Institute2003–2005
  • Docetaxel (TAXOTERE) &Bcl-2-Antisense OligonucleotideNational Center For Research Resources2000
  • Phase 2 Clinical Trials Of Oltipraz In Breast NeoplasiaDivision Of Cancer Prevention And Control1999–2000
  • Cancer And Acute Leukemia Group B (CALGB) Inst GrantNational Cancer Institute1998–2000
  • Phase II Clinical Trial Of Dehydroepi-AndrosteroneDivision Of Cancer Prevention And Control1999
  • Correlative Studies Of Angiogenesis In Breast CancerNational Cancer Institute1996–1997
  • Correlative Studies Of Angiogenesis In Breast CancerNational Cancer Institute1994–1996
  • Circulating C-NEU Protein In Breast Cancer PatientsNational Cancer Institute1991–1992
  • Immunodiagnostic Approaches To Breast CancerNational Cancer Institute1985–1987

Committees

  • Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present

Professional Memberships